Category Specific RSS

asthma

Adherium has begun manufacturing of their FDA approved respiratory inhaler

5-10% of the world’s population suffer from asthma. That’s over 23 million people, 7 million of whom are children.  Whilst…

4 years ago

4D Medical commences trading on the ASX, opens at 2x IPO Price

Investors that missed out on the IPO for medtech company 4D Medical (ASX: 4DX) have had no qualms buying the…

5 years ago

Respiri to enter asthma telehealth, wheezo commercialisation looms

Under new management, medtech company Respiri (ASX: RSH) is poised to enter the lucrative SaaS revenue market by leveraging their…

5 years ago